Juul Deploying Big Tobacco Playbook to Preempt Local Control

 

In a new white paper by Local Solutions Support Center (LSSC) and Illumination Investigations, Evan Vorpahl and Lisa Graves document how Juul has flooded statehouses with lobbyists to advance T-21 legislation, Commonly known as “Tobacco 21,” – bills to raise the purchase age of tobacco to 21, but that include poison pill measures preempting local governments from further regulating tobacco products.

As the company faces multiple crises related to its early marketing campaigns targeting teenagers and also the potential dangers of its product – the latest figures from the CDC confirm over 1000 serious illnesses and 18 deaths linked to vaping – it has leaned further into its ties to Big Tobacco. Cigarette giant Altria owns 35 percent of Juul, and its newly hired CEO and CRO are both former Altria executives. Now facing a May 2020 deadline for FDA approval, a federal flavor ban and numerous state and local regulations to protect public health, the company has dispatched its lobbying machine at the federal and state level to protect its profits.

This white paper dives into Juul’s deployment of the Big Tobacco playbook in its effort to stop localities from establishing their own rules to regulate its product. In the past few years Juul has increased its lobbying presence by over 800%, including 142 lobbyists in 48 states. The company succeeded in passing T-21 bills in three states in 2019 that preempt local government action and at present there is indication from grassroots on the ground that Juul may advance similar preemptive T-21 bills in atleast 10 states in 2020 – Arizona, Florida, Idaho, Kansas, Missouri, Nebraska, Oklahoma, Pennsylvania, South Carolina and West Virginia.

Juul’s state tactics reflect one of the starkest examples of how and why corporate special interests have latched on to the strategy of state preemption.

  • CannaAid and Peak: Something new for everyone.

Recent Articles

As a lifelong stoner, feminist, and teacher, Luna Stower does know how intersectional plant medicine can be.
“Whenever somebody sees ‘Sales Guru’ on my card, they ask how you become one,” he says. “I tell them that you spend your life in sales, and you go to Nepal to climb the Himalayas to meet the real gurus. You get the wisdom from them, then you bring it back down and apply it to your life.”
Cryptocurrency is taking the world by storm. It’s been over 15 years since the launch of Bitcoin, and although it’s more popular than ever before, it’s not the only form of crypto available today.
We know breaking up is hard to do, but sometimes the thrill is gone, and it’s time to move on. It doesn’t matter how long a brand’s been riding with you or how tight you are with the sales rep. If the product doesn’t perform, or worse, if the brand loses touch with the culture, it’s dead weight. And dead weight doesn’t just slow you down; it can drown you.
At HQ, we don’t shy away from controversy, but we also don’t exist to tear down legitimate players in the industry. We chose instead to invite both perspectives to weigh in.
Ali Bianco wants to elevate the cannabis world one pink pre-roll at a time. Since high school, she’s been sick of the stigma around weed and the idea that stoners are lazy and unkempt. Inspired by Blake Lively’s character smoking pink cigarettes in the 2011 film Hick, Ali decided to “make weed something beautiful” with a feminist kick.
In the early days, we bought flower based on two metrics: THC percentage and the vague promise of either indica or sativa. It was like ordering wine based on alcohol content and whether the label showed a beach or a mountain. We’ve come a long way.
I've witnessed firsthand how patient advocacy can profoundly change healthcare and people's lives. Today, I'm honored to lead ASA once again, as we intensify efforts to ensure medical cannabis reaches all patients who need it, fully integrated into our nation's healthcare system.